UROMITEXAN 400mg / 4ml injectible solution medication leaflet

V03AF01 mesna • Various | All other therapeutic products | Detoxifying agents for antineoplastic treatment

Mesna is a medication used to protect against bladder toxicity caused by chemotherapy drugs such as cyclophosphamide and ifosfamide. It works by binding to toxic metabolites in the urine, preventing bladder damage.

The medication is administered orally or intravenously, as directed by a doctor, usually during chemotherapy. It is important for patients to follow the treatment regimen and consume adequate fluids to maintain proper diuresis.

Patients should be aware of potential side effects, such as nausea, vomiting, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and diarrhea. In rare cases, severe reactions such as allergic reactions or skin rashes may occur. Patients should be informed of these risks before use.

General data about UROMITEXAN 400mg / 4ml

Substance: mesna

Date of last drug list: 01-06-2025

Commercial code: W70298001

Concentration: 400mg / 4ml

Pharmaceutical form: injectible solution

Packing volume: 4ml

Product type: original

Price: 175.93 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BAXTER ONCOLOGY GMBH - GERMANIA

Holder: BAXTER HEALTHCARE S.R.L. - ROMANIA

Number: 7623/2015/01

Shelf life: 5 years

Pharmaceutical forms available for mesna

Concentrations available for mesna

400mg, 400mg/4ml, 600mg

Compensation lists for UROMITEXAN 400mg / 4ml BAXHESRL

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

175.93 RON

175.93 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

175.93 RON

175.93 RON

0.00 RON